Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity.

Patel RD, Blair MP, Shapiro MJ, Lichtenstein SJ. Significant treatment failure with intravitreous bevacizumab for retinopathy of prematurity. Arch Ophthalmol. 2012 Jun; 130(6):801-2.

View in: PubMed

subject areas

Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Disease Progression
Gestational Age
Humans
Infant, Extremely Low Birth Weight
Infant, Newborn
Intravitreal Injections
Recurrence
Retinal Detachment
Retinopathy of Prematurity
Treatment Failure
Ultrasonography
Vascular Endothelial Growth Factor A

authors with profiles

Michael P Blair